|Articles|June 29, 2016
Manufacturing Controlled Substances
Advertisement
David Mayers, president of Wellspring Pharma Services sat down with Pharmaceutical Technology to discuss the manufacture of controlled substances.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
3
PharmTech Weekly News Roundup — Week of November 10, 2025
4
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
5
